Daily Market Brief · Monday, 3 August 2026
Yuan Dao Communications faces potential delisting amid CSRC investigation
Yuan Dao Communications Co., Ltd. has received a risk warning from the CSRC regarding possible delisting due to financial misrepresentation. Other companies, including Minde Electronics and Xintian Technology, are also making significant moves.
63 material announcements from 39 companies
Today's market saw significant developments, particularly concerning Yuan Dao Communications Co., Ltd. (301139), which faces potential delisting due to a notice from the China Securities Regulatory Commission (CSRC) over alleged financial misrepresentation. The company is cooperating with the investigation and advises investors to remain vigilant.
Earnings & Performance
- Xinxiang Chemical Fiber Co., Ltd. (000949) released its 2025 annual audit report, receiving an unqualified opinion from auditors, confirming its financial statements accurately reflect its position and performance.
Deals & Restructuring
- Xintian Technology Co., Ltd. (300615) announced a share transfer agreement with Shenzhen Yuanqi Infinite Technology Partnership, involving 43,422,354 shares, which will result in a change of control. This transaction is valued at approximately RMB 720 million.
- Minde Electronics Co., Ltd. (300656) is responding to an audit inquiry regarding its proposed RMB 1 billion private placement for a semiconductor project, addressing project feasibility and previous fundraising performance.
- Shenghui Technology Co., Ltd. (300423) terminated its plan to issue shares for asset purchase, opting instead for a cash transaction due to market conditions affecting Hepsun Energy.
Regulatory & Governance
- Yuan Dao Communications Co., Ltd. (301139) received a risk warning from the CSRC, which could lead to delisting due to financial data misrepresentation.
- ST Hengxin Co., Ltd. (300081) is facing regulatory actions for information disclosure violations and has corrected its 2022 annual report.
- Digital China Information Service Group Company Ltd. (000555) announced that its application for a share issuance to specific targets has been accepted by the Shenzhen Stock Exchange.
Other Notable Developments
- Jialichuang Co., Ltd. (001232) confirmed its IPO on the Shenzhen Main Board set for August 4, 2026, with an emphasis on potential market risks.
- CIMC Vehicles (Group) Co., Ltd. (301039) updated on the US Department of Commerce's investigation into anti-subsidy and anti-dumping measures affecting its products.
- Huafon Chemical Co., Ltd. (002064) is progressing with its proposed share issuance and asset acquisition, pending further approvals.
- Beilu Pharmaceutical Co., Ltd. (300016) announced its product selection in the national centralized drug procurement, expected to enhance market share.
- Hunan Junxin Environmental Protection Co., Ltd. (301109) received filing confirmation from the CSRC for its planned overseas listing of H shares.
Investors are encouraged to monitor these developments closely as they may impact market dynamics and individual company performances.
In this brief
- 14th Risk Warning Announcement Regarding Potential Major Violation Delisting of Company Shares
- Reply Report on the Audit Inquiry Letter Regarding the Application for Issuance of Shares to Specific Objects by Minde Electronics
- Detailed Report on Changes in Equity for Shenzhen Sunway Communication Co., Ltd.
- Announcement Regarding Signing of Share Transfer Agreement by Controlling Shareholder, Actual Controller, and Related Parties, and Proposed Change of Control
- Financial Advisor's Verification Opinion of Beijing Bestar Securities Investment Consulting Co., Ltd. on the Report on Change of Equity in Shenzhen Sunway Technology Co., Ltd.
- Legal Opinion of Guangdong Sundial Law Firm on the Initial Public Offering and Main Board Listing of Shenzhen Jialichuang Technology Group Co., Ltd.
- Announcement on Terminating Share Issuance for Asset Purchase and Fundraising and Continuing Negotiation for Cash Asset Purchase
- Prospectus for 2026 Non-Public Issuance of A-Shares (July 2026)
- Listing Announcement for Initial Public Offering and Main Board Listing
- Digital China Information Service Group Company Ltd. 2026 Prospectus for Issuance of Shares to Specific Targets and Listing on the Main Board (Draft)
Digital China Information Service Group Company Ltd. (000555)
- Announcement on Progress of Judicial Auction of Shares Held by Shareholder Exceeding 5%, Change in Equity, and Change of Largest Shareholder
- Announcement on the Hong Kong Stock Exchange's Review of the Company's Issuance of H Shares
- BDO China Shu Lun Pan CPAs LLP's Response to the Audit Inquiry Letter Regarding the Application for Issuance of Shares to Specific Targets by Shenzhen MinDe Electronics Technology Co., Ltd.
- Great Wall Securities Co., Ltd.'s Issuance Sponsorship Letter Regarding Shenzhen Minde Electronics Technology Co., Ltd.'s 2026 Annual Issuance of A-Shares to Specific Targets
- 2026 Prospectus for Issuance of A-Shares to Specific Targets (Revised Draft)
- Announcement on Progress of Investigation into Anti-Subsidy and Anti-Dumping by US Department of Commerce Concerning Van-Type Trailers and Subassemblies Thereof Produced in Mexico, Canada, and China by Vanguard Global Trailer Holding and Its Three Subsidiaries
- Announcement on Resolutions of the 14th Extraordinary Board Meeting of the Fifth Board of Directors
- Announcement on the Put Option for Jianfan Convertible Bonds
- Announcement on Progress of Matters Regarding Company Stock Being Subject to Other Risk Warning
- Announcement on Progress of Litigation
- Announcement on Progress of Matters Regarding Company's Stock Being Subject to Additional Risk Warnings
- Progress Announcement on Major Litigation of the Company
- Announcement on Capital Increase and Equity Expansion of Wholly-Owned Subsidiary, Introduction of Investors, and Partial Waiver of Rights by the Company
- Announcement on Subsidiaries' Preliminary Selection in National Centralized Drug Procurement
- Announcement on the Proposed Selection of Pioglitazone and Metformin Hydrochloride Extended-Release Tablets in the 12th National Centralized Drug Procurement
- Announcement Regarding Wholly-Owned Subsidiary Receiving Drug Supplemental Application Approval Notice and Proposed Winning of National Centralized Drug Procurement
- Announcement on Company Products Being Selected for National Centralized Drug Procurement
- Announcement on the Proposed Winning Bids of Wholly-Owned Subsidiary in the 12th National Centralized Drug Procurement
- Simplified Report on Change of Equity (Xue Feng)
- Simplified Report on Change of Equity (Shi Weiping)
- Simplified Report on Changes in Equity (Liu Hui)
- Announcement on the Progress of the Planned Change of Company Control and Resumption of Trading
- Announcement on Proposed Winning Bids for the 12th Batch of National Centralized Drug Procurement
- Announcement on Company's Successful Bidding in National Centralized Drug Procurement
- Announcement on Major Litigation Involving a Wholly-Owned Subsidiary
- Announcement on the Progress of the Proposed Issuance of Shares and Payment of Cash to Acquire Assets and Related Party Transactions
- Guotai Haitong Securities Co., Ltd. Listing Sponsorship Letter Regarding the Initial Public Offering and Main Board Listing of Shenzhen JLC Technology Group Co., Ltd.
- Announcement of Listing of Initial Public Offering of Shares on the Main Board
- Announcement on Company's Preliminary Selection in the 12th National Centralized Drug Procurement
- Announcement on the Suspension of Company Shares
- King & Wood Mallesons Legal Opinion on the 2026 Annual Issuance of Shares to Specific Targets by Digital China Information Service Group Co., Ltd.
Digital China Information Service Group Company Ltd. (000555)
- Simplified Equity Change Report (Yuan Xu)
- Announcement on Progress of Matters Regarding Company Stock Being Subject to Other Risk Warnings
- Guangdong Huashang Law Firm's Supplementary Legal Opinion on Shenzhen Mind Electronic Technology Co., Ltd.'s Issuance of Shares to Specific Objects (I)
- Announcement on Reply to Inquiry Letter for Specific Object Share Issuance and Update of Application Documents Such as Prospectus
- Announcement on Holding an Investor Briefing on the Termination of Major Asset Restructuring
- Announcement on the Disposal of Equity in an Investee Company
- Announcement of Resolutions of the 6th Board of Directors' 9th Meeting
- Grandall Law Firm (Shenzhen) Legal Opinion on the Put Option for Grandall Bio-Pharmaceuticals Co., Ltd. Convertible Bonds
- Announcement on Progress of Land Use Rights Purchase and Project Investment
- Announcement on Cumulative Litigation and Arbitration Matters
- Announcement Regarding the Proposed Winning of Bids in the National Organized Centralized Drug Procurement
- Announcement of Resolutions of the Fourteenth Meeting of the Fourth Board of Directors
- Announcement on Obtaining EU CEP Certificate for Octreotide API
- Announcement on the Company's Controlling Shareholder's Plan to Increase Shareholding and Obtaining Loan Commitment Letter from Financial Institution
- Report on Temporary Entrusted Management Affairs Regarding Changes in Chairman and Vice Chairman and Election of Members to Special Committees of the Ninth Board of Directors of Modern Investment Co., Ltd.
- Announcement of Preliminary Winning of Project
- Issuer's Financial Report and Audit Report for the Most Recent Year and Financial Report for the Most Recent Period (July 2026)
- Listing Sponsorship Letter (July 2026)
- Announcement on Obtaining Filing from CSRC for Issuing Overseas Listed Foreign Shares (H Shares)
- Announcement on Company's Controlling Subsidiary Receiving a Bid Notification
- Announcement on Company's Provisional Selection in National Centralized Drug Procurement
- Announcement on the Acceptance of Application for Issuance of Shares to Specific Objects by Shenzhen Stock Exchange
Digital China Information Service Group Company Ltd. (000555)
This brief is generated by AI from English translations of SZSE filings and may contain errors. It is for information only and is not investment advice.